Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by KAMRAN AHRAR and SURENA MATIN.
KAMRAN AHRAR
Connection Strength
3.553
SURENA MATIN
  1. Nephron-sparing probe ablative therapy: long-term outcomes. Curr Opin Urol. 2008 Mar; 18(2):150-6.
    View in: PubMed
    Score: 0.311
  2. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors. Expert Rev Anticancer Ther. 2006 Dec; 6(12):1735-44.
    View in: PubMed
    Score: 0.285
  3. Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center Experience. Cancers (Basel). 2024 May 10; 16(10).
    View in: PubMed
    Score: 0.239
  4. Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience. Eur Radiol. 2024 Sep; 34(9):5551-5560.
    View in: PubMed
    Score: 0.236
  5. Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy. Eur Urol Open Sci. 2023 Nov; 57:45-50.
    View in: PubMed
    Score: 0.229
  6. Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience. Cancers (Basel). 2023 Jan 31; 15(3).
    View in: PubMed
    Score: 0.219
  7. Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies. AJR Am J Roentgenol. 2021 07; 217(1):157-163.
    View in: PubMed
    Score: 0.194
  8. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359.
    View in: PubMed
    Score: 0.162
  9. Predicting and Determining the Success of Percutaneous Ablation. J Urol. 2016 07; 196(1):7-8.
    View in: PubMed
    Score: 0.137
  10. Salvage surgery after energy ablation for renal masses. BJU Int. 2015 Jan; 115(1):74-80.
    View in: PubMed
    Score: 0.125
  11. Safety and diagnostic accuracy of percutaneous biopsy in upper tract urothelial carcinoma. BJU Int. 2015 Apr; 115(4):625-32.
    View in: PubMed
    Score: 0.123
  12. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T. Invest Radiol. 2013 Jun; 48(6):437-44.
    View in: PubMed
    Score: 0.112
  13. Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU Int. 2013 May; 111(6):997-1005.
    View in: PubMed
    Score: 0.110
  14. Ablative therapies in renal cell carcinoma. Minerva Urol Nefrol. 2011 Sep; 63(3):237-50.
    View in: PubMed
    Score: 0.099
  15. Chyluria after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2011 Jul; 22(7):924-7.
    View in: PubMed
    Score: 0.097
  16. Ablation of kidney tumors. Surg Oncol Clin N Am. 2011 Apr; 20(2):341-53, viii.
    View in: PubMed
    Score: 0.094
  17. Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urol. 2010 Nov; 184(5):1882-7.
    View in: PubMed
    Score: 0.093
  18. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2010 May; 21(5):690-5.
    View in: PubMed
    Score: 0.090
  19. Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int. 2008 Sep; 102(8):940-5.
    View in: PubMed
    Score: 0.079
  20. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol. 2007 Sep; 18(9):1186-91.
    View in: PubMed
    Score: 0.075
  21. Is radiofrequency ablation safe for solitary kidneys? Urology. 2007 May; 69(5):819-23; discussion 823.
    View in: PubMed
    Score: 0.073
  22. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006 Nov; 176(5):1973-7.
    View in: PubMed
    Score: 0.071
  23. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. AJR Am J Roentgenol. 2005 Jul; 185(1):86-8.
    View in: PubMed
    Score: 0.065
  24. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005 May; 16(5):679-88.
    View in: PubMed
    Score: 0.064
  25. Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nat Commun. 2021 11 04; 12(1):6375.
    View in: PubMed
    Score: 0.050
  26. Management of Residual or Recurrent Disease Following Thermal Ablation of Renal Cortical Tumors. J Kidney Cancer VHL. 2020 Jun; 7(2):1-5.
    View in: PubMed
    Score: 0.046
  27. Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy: Correlation with RENAL Nephrometry Scores. Cardiovasc Intervent Radiol. 2017 Feb; 40(2):202-209.
    View in: PubMed
    Score: 0.035
  28. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int. 2010 Feb; 105(4):496-500.
    View in: PubMed
    Score: 0.022
  29. Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques. Urol Oncol. 2008 Jan-Feb; 26(1):37-42.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.